KOD Research and Charts

KOD - Kodiak Sciences Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-16 (Delayed quote data 2025-01-06)

Last 9.32	Change ⇑ +0.20 (+2.19%)	Volume 388,919
	Open 9.11	High 9.84	Low 9.02

8EMA (Daily) 9.37	40EMA (Daily) 7.77	50EMA (Daily) 7.29	STO (Daily) 40.295	MACD Hist (Daily) -0.307
8EMA (Weekly) 8.184	40EMA (Weekly) 5.15	50EMA (Weekly) 5.10	STO (Weekly) 72.884	MACD Hist (Weekly) 1.030


Company Profile
Kodiak Sciences Inc is a clinical-stage company. It is engaged in developing innovative therapeutics to treat the high prevalence of ophthalmic diseases. The most advanced product candidate of the group is KSI-301, a biologic therapy built with an antibody biopolymer conjugate platform, which is designed to maintain potent and effective drug levels in ocular tissue.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.